Renal hyperfiltration is associated with glucose-dependent changes in fractional excretion of sodium in patients with uncomplicated type 1 diabetes

Diabetes Care

Volumn 37, Issue 10, 2014, Pages 2774-2781

  Yang, Gary K ^a   Har, Ronnie L H ^a   Lytvyn, Yuliya ^a   Yip, Paul ^b   Cherney, David Z I ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NEUROHORMONE; SODIUM; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; GLUCOSE URINE LEVEL; HEART RATE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY HYPERFILTRATION; KIDNEY PLASMA FLOW; KIDNEY TUBULE ABSORPTION; MALE; SODIUM BLOOD LEVEL; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT; ADOLESCENT; ANIMAL; BLOOD; CASE CONTROL STUDY; DIABETIC NEPHROPATHIES; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ADOLESCENT; ADULT; ANIMALS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; KIDNEY; MALE; SODIUM; YOUNG ADULT;

EID: 84908192497     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0798     Document Type: Article

References (48)

1. Molitch ME, DeFronzo RA, Franz MJ, et al.; American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004;27(Suppl. 1):S79-S83.
2. Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010;53: 2093-2104.
3. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009;52:691-697.
4. Yang GK, Maahs DM, Perkins BA, Cherney DZ. Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus. PLoS ONE 2013;8:e68908.
5. Premaratne E, Macisaac RJ, Tsalamandris C, Panagiotopoulos S, Smith T, Jerums G. Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate. Diabetologia 2005;48:2486-2493.
6. Maric-Bilkan C. Obesity and diabetic kidney disease. Med Clin North Am 2013;97:59-74.
7. Marouf R, Mojiminiyi O, Abdella N, Kortom M, Al Wazzan H. Comparison of renal function markers in Kuwaiti patients with sickle cell disease. J Clin Pathol 2006;59:345-351.
8. Luyckx VA, Brenner BM. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl 2005;68:S68-S77.
9. da Costa Rodrigues T, Pecis M, Azevedo MJ, Esteves JF, Gross JL. Ambulatory blood pressure monitoring and progression of retinopathy in normotensive, normoalbuminuric type 1 diabetic patients: a 6-year follow-up study. Diabetes Res Clin Pract 2006;74:135-140.
10. Imano E, Miyatsuka T, Motomura M, et al. Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria. Diabetes Res Clin Pract 2001; 52:185-191.
11. Marcovecchio ML, Dalton RN, Schwarze CP, et al. Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes. Diabetologia 2009;52:1173-1181.
12. Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulocentric view. J Am Soc Nephrol 2003;14:530- 537.
13. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999; 10:2569-2576.
14. Pollock CA, Lawrence JR, Field MJ. Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitus. Am J Physiol 1991;260:F946-F952.
15. Cherney DZ, Perkins BA, Soleymanlou N, et al. The renal hemodynamic effect of sodiumglucose cotransporter 2 inhibition inhibition in patients with type 1 diabetes. Circulation 2014; 129:587-597.
16. Perkins BA, Sochett EB, Cherney DZ. Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes. Clin Exp Hypertens 2012;34:606-611.
17. Vervoort G, Veldman B, Berden JH, Smits P, Wetzels JF. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest 2005;35:330-336.
18. Pruijm M, Wuerzner G, Maillard M, et al. Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. Nephrol Dial Transplant 2010;25:2225-2231.
19. Cherney DZ, Lai V, Scholey JW, Miller JA, Zinman B, Reich HN. Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care 2010;33:361-365.
20. Cherney DZ, Reich HN, Jiang S, et al. Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2012;303: R710-R718.
21. Cherney DZ, Reich HN, Miller JA, et al. Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2010;299:R206-R214.
22. Cherney DZ, Miller JA, Scholey JW, et al. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes. Diabetes 2008;57:688-695.
23. Cherney DZ, Miller JA, Scholey JW, et al. Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. Diabetes Care 2010;33:1344-1346.
24. Davidson WD, Sackner MA. Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med 1963;62:351-356.
25. Jung K, Klotzek S, Schulze BD. Refinements of assays for low concentrations of inulin in serum. Nephron 1990;54:360-361.
26. Florijn KW, Barendregt JN, Lentjes EG, et al. Glomerular filtration rate measurement by "singleshot" injection of inulin. Kidney Int 1994;46:252- 259.
27. Hopkins PN, Lifton RP, Hollenberg NK, et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996;14:199-207.
28. Hannedouche TP, Delgado AG, Gnionsahe DA, Boitard C, Lacour B, Grünfeld JP. Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int 1990; 37:1126-1133.
29. Brøchner-Mortensen J, Støckel M, Sørensen PJ, Nielsen AH, Ditzel J. Proximal glomerulo-tubular balance in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1984;27:189-192.
30. Aires I, Calado J. BI-10773, a sodiumglucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus. Curr Opin Investig Drugs 2010;11:1182-1190.
31. Arakawa K, Ishihara T, Oku A, et al. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095. Br J Pharmacol 2001;132:578-586.
32. Malatiali S, Francis I, Barac-Nieto M. Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats. Exp Diabetes Res 2008;2008:30540378.
33. Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 1999;10: 1778-1785.
34. Nosadini R, Sambataro M, Thomaseth K, et al. Role of hyperglycemia and insulin resistance in determining sodium retention in noninsulin- dependent diabetes. Kidney Int 1993;44: 139-146.
35. Freitas HS, Anhê GF, Melo KF, et al. Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity. Endocrinology 2008;149:717-724.
36. DeFronzo RA, Goldberg M, Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 1976;58:83-90.
37. Milt ényi M, Körner A, Tulassay T, Szabó A. Tubular dysfunction in type I diabetes mellitus. Arch Dis Child 1985;60:929-931.
38. Cherney D, Maahs DM. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2458-2459.
39. Price DA, Porter LE, Gordon M, et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999;10:2382- 2391.
40. Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 2006;17:1703-1709.
41. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
42. Pecis M, Azevedo MJ, Gross JL. Glomerular hyperfiltration is associated with blood pressure abnormalities in normotensive normoalbuminuric IDDM patients. Diabetes Care 1997;20:1329-1333.
43. Christiansen EH, Mølgaard H, Christensen PD, Sørensen KE, Christensen CK, Mogensen CE. Increased left ventricular systolic function in insulin dependent diabetic patients with normal albumin excretion. Eur Heart J 1998;19: 1735-1739.
44. Nørgaard K, Feldt-Rasmussen B. Sodium retention and insulin treatment in insulin-dependent diabetes mellitus. Acta Diabetol 1994;31:19- 25.
45. Cherney DZ, Sochett EB, Dekker MG, Perkins BA. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes. Diabet Med 2010;27:1358-1365.
46. Maahs DM, Caramori L, Cherney DZ, et al.; PERL Consortium. Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep 2013;13:550-559.
47. Miracle CM, Rieg T, Mansoury H, Vallon V, Thomson SC. Ornithine decarboxylase inhibitor eliminates hyperresponsiveness of the early diabetic proximal tubule to dietary salt. Am J Physiol Renal Physiol 2008;295:F995- F1002.
48. Ganz MB, Hawkins K, Reilly RF. High glucose induces the activity and expression of Na(+)/H(+) exchange in glomerular mesangial cells. Am J Physiol Renal Physiol 2000;278:F91-F96.